Locations:

Research

June 5, 2017/Cancer/Research

Trial Finds Maximum Tolerable Dose for Combination Therapy for Metastatic Renal Cell Carcinoma Patients

Axitinib and crizotinib stabilized disease in most

June 4, 2017/Cancer/Research

Maximum Tolerable Doses for Adding Cell Checkpoint Inhibitor to Standard of Care for Glioblastoma Patients

Inhibitor stops DNA repair of cancer cells

June 4, 2017/Cancer/Research

Study Combines Targeted Therapy With Immune-System Therapy for Patients with Advanced Renal Cell Cancer

Doctors will analyze whether survival improves

June 3, 2017/Cancer/Research

A Novel Approach: Aggressive Chemotherapy Regimen Before Surgery in Resectable Pancreatic Adenocarcinoma

May increase some pancreatic cancer survival rates

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

May 23, 2017/Cancer/Research

A New Strategy for Cancer Treatments

Moving from whack-a-mole to chess

May 12, 2017/Cancer/Research

Featured Cancer Clinical Trials

Learn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies.

May 8, 2017/Cancer/Research

Promising New Combination Therapy for Advanced, HER2+ Breast Cancer Shown Safe and Effective

Neratinib and trastuzumab emtansine (T-DM1) combination potent and well tolerated

March 15, 2017/Cancer/Research

Cleveland Clinic Researcher Receives $5.5 Million Outstanding Investigator Award

Maciejewski honored for work in bone marrow failure syndromes

February 27, 2017/Cancer/Research

Multigene Panel Testing Reveals Mutations in Early Onset CRC Patients

Results suggest: Offer broad testing to all of them

February 23, 2017/Cancer/Research

Sunitinib Treatment Breaks Feasible for Metastatic Renal Cell Carcinoma

Clinical efficacy uncompromised in previously untreated patients

BackPage 30 of 42Next